ABBV vs WGRX

AbbVie Inc. (ABBV) is a well-established mega-cap pharmaceutical company with a robust product portfolio, strong financial health, and a leading position in key therapeutic areas. It excels as a stable dividend payer and a defensive holding. However, its fundamental characteristics, including its immense market capitalization ($397.29B), the mature nature of the pharmaceutical industry, high R&D c...

Wellgistics Health Inc. (WGRX) remains an extremely high-risk, speculative opportunity with a negligible chance of 10x growth within 3-5 years without a radical turnaround. The company faces an imminent Nasdaq delisting threat by June 8, 2026, though it has approved a reverse stock split to address this. While the termination of one dilutive settlement is positive, the $1.25M in new debt adds to f...